Showing results (1791-1800 of 1,896) with videos related to

Sort By:
Pageof 190
Antimicrobial Agents and Chemotherapy|November 15, 2024
The extended recovery ring-stage survival assay is a scalable alternative for artemisinin susceptibility phenotyping of fresh <i>Plasmodium falciparum</i> isolatesMartin Okitwi, Douglas A Shoue, Lisa A Checkley, et al.
American Journal of Physiology. Renal Physiology|April 18, 2024
Animal models to study cognitive impairment of chronic kidney diseasePedro H Imenez Silva, Marion Pepin, Andreja Figurek, et al.
The Journal of Infectious Diseases|July 28, 2022
Malaria Transmission Intensity Likely Modifies RTS, S/AS01 Efficacy Due to a Rebound Effect in Ghana, Malawi, and GabonGriffin J Bell, Varun Goel, Paulin Essone, et al.
Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers studyDeus S Ishengoma, Celine I Mandara, Catherine Bakari, et al.
Open Biology|July 8, 2025
<i>PIEZO1</i> variant implications for biological understanding and human healthChew W Cheng, Sophie L Earle, Oleksandr V Povstyan, et al.
Medrxiv : the Preprint Server for Health Sciences|May 15, 2024
High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencingNeeva Wernsman Young, Pierre Gashema, David Giesbrecht, et al.
Frontiers in Epidemiology|March 8, 2024
Low Complexity of Infection Is Associated With Molecular Persistence of <i>Plasmodium falciparum</i> in Kenya and TanzaniaHillary M Topazian, Kara A Moser, Billy Ngasala, et al.
The Lancet. Infectious Diseases|August 19, 2024
Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistanceDeus S Ishengoma, Celine I Mandara, Catherine Bakari, et al.
Pageof 190